Comparison of changes FEV1 in Bronchodilator and Corticosteroid Combinations for Patients Chronic Obstructive Pulmonary Disease Stable in Balai Besar Kesehatan Paru Masyarakat (BBKPM) Hospital Surakarta

Fajar Amirulah Apoteker(1*),

(1) STIKES BANI SALEH
(*) Corresponding Author

Abstract


The objective of the present study is to study the relationship for use bronchodilator combined to corticosteroids between Dyspnoea BORG Scale, respiratory rate (rr) and Forced Expiratory Volume in first second (FEV1) in COPD patients. This Prospective observational study was conducted on 57 patient during November 2018 and April 2019 at Balai Besar Kesehatan Paru Masyarakat Hospital, Surakarta. The characteristic patient COPD include gender, age, smoker or non-smoker, worker or non-worker correlated not significanly with use bronchodilator combined to corticosteroids  (p>0,05). % FEV1 and respiratory rate (rr) not significanly for COPD patients with use bronchodilator combined to corticosteroid  (p>0,05). Dyspnoea BORG Scale correlated significanly for COPD patients with use bronchodilator combined to corticosteroid  (p<0,05). We conclude that in COPD patients, the combined use of bronchodilator with corticosteroids is more effective in reducing the dyspnoea than bronchodilator alone.


References


Global Initiative fo Chronic Obstructive Lung Disease (GOLD). Global Strategy for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2017. Diakses 21 Agustus 2018.

Raherison, C., & Girodet, P. O. Epidemiology of COPD. European Respiratory Review, 2009; 18(114), 213-221.

Dinas Kesehatan Provinsi Jawa Tengah. Profil kesehatan provinsi Jawa Tengah tahun 2015. Semarang: Dinkesjateng. 2015.

Williams, Dennis M., Bourdet, Sharya V. Chronic Obstructive Pulmonary Disease. In : Dipiro, J., et al., (Eds). Pharmacotherapy A Pathophysiologic Approach seventh edition. New York: Mc Graw-Hill. 2014; pp. 528-550.

Han, M. K., & Lazarus, S. C. COPD: clinical diagnosis and management. In Murray and Nadel's Textbook of Respiratory Medicine (Sixth Edition). 2016; pp. 767-785.

Valero C, Monteagudo M, Lagostera M, Bayona X, Granollers S, Acedo M, Ferro J, Rodriquez-Latre J, Almeda J, Almeda J, Munoz L: Evaluation of a combined strategy directed towards health-care professionals adn patients with chronic obstuctive pulmonary disease (COPD): information adn health education feedback for improving clinical monitoring and quality-of-life. BMC Public Health. 2009,9:442-10.1186/1471-2458-9-442.

Chourpiliadis, Bhardwaj A. Physiology, Respiratory Rate. StatPearls Publishing. 2019.

Antonio A.M, Castro, Claudia Kumpel, Rosana Chaves Rangueri, Mauricio Dalcin oliveira, Rodrigo Alves Dornelles, Emerson Roberto Brito, Tania Maria Seki, Elias F. Porto. Daily activities are sufficient to induce dynamic pulmonary hyperinflation and dyspnea in chronic obstructive pulmonary disease patients.CLINICS. 2012;67(4):319-325.

Ernesto Crisafulli, Enrico M. Clini. Measures of dyspnea in pulmonary rehabilitation. Multidisciplinary Respiratory Medicine. 2010; 5(3): 202-210.

Jeffrey M Haynes. Randomized Controlled Trial of a Breath-Activated Nebulizer in Patients with Exacerbation of COPD. Respiratory Care. 2012 :Vol.57 No.9.

Philippe Gagnon, Jordan A Guenette, Daniel Langet, Louis Laviolette, Vincent Mainguy, Francois Maltais, Fernanda Ribeiro, Didier Saey. Pathogenesis of hyperinflation in chronic obstructive pulmonary disease. International Journal of COPD. 2019 :9, 187-201.

Gueho F, Beaune S, Devillier P, Urien S, Faisy C. Modelling the effectiveness of nebulized terbutaline for decompensated chronic obstructive pulmonary disease patients in the emergency departement. Prancis. Medicine (Baltimore). 2016; 95(32)e4553.

Nannini, L. J., Poole, P., Milan, S. J., & Kesterton, A. Combined corticosteroid and long-acting beta₂-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease. 2013.

Hogg JC, Chu F, Utokaparch S, Woods R, Elliot WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med; 2004; 350(26): 2645-53.

Han, M. K., & Lazarus, S. C. COPD: clinical diagnosis and management. In Murray and Nadel's Textbook of Respiratory Medicine (Sixth Edition) 2016 : (pp. 767-785).

Ramlal SK, Visser FJ, Hop WC, Dekhuijzen PN, Heijdra YF. The effect of bronchodilators administered via aerochamber or a nebulizer on inspiratory lung function parameters. Respiratory Medicine 2013; 107, 1393-1399.

Jiang DH, Wang X, Liu LS, Ji DD, Zhang N. The effect of ventilator mask atomization inhalation of ipratropium bromide and budesonide liquid in the treatment of COPD in acute exacerbation period on circulating levels of inflammation and prognosis. European Review Medical and Pharmacological Sciences, 2017; 21: 5211-5218.

Jeffrey M Haynes. Randomized Controlled Trial of a Breath-Activated Nebulizer in Patients with Exacerbation of COPD. Respiratory Care, 2012; Vol.57 No.9.

West JB. Respiratory physsiology : the essential. 4th ed. Baltimore: Williams and Wilkins. 1990.




DOI: http://dx.doi.org/10.30737/jafi.v2i1.923

Article Metrics

Abstract view : 120 times
PDF (Bahasa Indonesia) - 268 times

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Jurnal Inovasi Farmasi Indonesia (JAFI)



Jurnal inovasi farmasi indonesia terindeks di ;